| [1] |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer,2015,136(5):E359-386.
|
| [2] |
陈万青,郑荣寿.中国女性乳腺癌发病死亡和生存状况[J].中国肿瘤临床,2015,42(13):668-674.
|
| [3] |
Lakhtakia R. A brief history of breast cancer: part I: surgical domination reinvented [J]. Sultan Qaboos Univ Med J, 2014,14(2):e166-169.
|
| [4] |
Crane-Okada R, Wascher RA, Elashoff D, et al. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer [J].Ann Surg Oncol,2008,15(7):1996-2005.
|
| [5] |
Mansel RE, Fallowfield L, Kissin M, et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial [J]. J Natl Cancer Inst,2006,98(9):599-609.
|
| [6] |
Cabanas RM. An approach for the treatment of penile carcinoma [J].Cancer,1977,39(2):456-466.
|
| [7] |
Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe[J].Surg Oncol,1993,2(6):335-340.
|
| [8] |
Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast Cancer[J]. J Clin Oncol,2005,23(30):7703-7720.
|
| [9] |
江泽飞,王永胜.2009年第11 届St. Galle 国际早期乳腺癌治疗研讨会:争议与共识[J/CD].中华乳腺病杂志(电子版),2009,3(4):381-386.
|
| [10] |
邵志敏,李俊杰. 2015 版《中国抗癌协会乳腺癌诊治指南与规范》:外科部分解读[J/CD].中华乳腺病杂志(电子版), 2016, 10(1):1-5.
|
| [11] |
Lyman GH, Temin S, Edge SB, et al. Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update[J]. J Clin Oncol,2014,32(13):1365-1386.
|
| [12] |
中国抗癌协会乳腺癌专业委员会.中国抗癌协会乳腺癌诊治指南与规范(2015 版)[J]. 中国癌症杂志,2015,25(9):692-754.
|
| [13] |
Harlow SP, Krag DN, Julian TB, et al. Prerandomization surgical training for the National Surgical Adjuvant Breast and Bowel Project(NSABP) B-32 trial - A randomized phase Ⅲclinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer[J].Ann Surg,2005,241(1):48-54.
|
| [14] |
Krag DN, Anderson SJ, Julian TB, et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial[J]. Lancet Oncol,2010,11(10):927-933.
|
| [15] |
刘裔莎,魏兵,杨雯娟,等.美国癌症联合会乳腺癌分期(第七版)简介[J].中华病理学杂志,2010,39(11):787-790.
|
| [16] |
Giuliano AE,McCall L,Beitsch P,et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial [J]. Ann Surg,2010,252(3):426-432.
|
| [17] |
Yi M, Kuerer HM, Mittendorf EA, et al. Impact of the American college of surgeons oncology group Z0011 criteria applied to a contemporary patient population [J]. J Am Coll Surg, 2013,216(1):105-113.
|
| [18] |
Chung A, Gangi A, Mirocha J, et al. Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery [J]. Ann Surg Oncol,2015,22(4):1128-1132.
|
| [19] |
Miller CL, Specht MC, Skolny MN, et al. Risk of lymphedema after mastectomy: potential benefit of applying ACOSOG Z0011 protocol to mastectomy patients[J]. Breast Cancer Res Treat,2014,144(1):71-77.
|
| [20] |
Donker M,van Tienhoven G,Straver ME,et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label,phase 3 non-inferiority trial [J]. Lancet Oncol, 2014, 15 (12):1303-1310.
|
| [21] |
Galimberti V, Cole BF, Zurrida S, et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases(IBCSG 23-01): a phase 3 randomised controlled trial[J]. Lancet Oncol,2013,14(4):297-305.
|
| [22] |
Kwon Y, Ro J, Kang HS, et al. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients [J]. Oncol Rep, 2011,25(4):1063-1071.
|
| [23] |
Asaga S,Kinoshita T,Hojo T,et al. Predictive factors for non-sentinel lymph node metastasis in patients with clinically node-negative ipsilateral multiple breast cancer treated with total mastectomy[J].Clin Breast Cancer,2015,15(5):362-369.
|
| [24] |
Spillane AJ, Brennan ME. Accuracy of sentinel lymph node biopsy in large and multifocal/multicentric breast carcinoma-a systematic review[J]. Eur J Surg Oncol,2011,37(5):371-385.
|
| [25] |
Moody LC,Wen X,McKnight T,et al. Indications for sentinel lymph node biopsy in multifocal and multicentric breast cancer[J]. Surgery,2012,152(3):389-396.
|
| [26] |
Walters LL,Pang JC,Zhao L,et al. Ductal carcinoma in situ with distorting sclerosis on core biopsy may be predictive of upstaging on excision[J]. Histopathology,2015,66(4):577-586.
|
| [27] |
Zetterlund L, Stemme S,Arnrup H,et al. Incidence of and risk factors for sentinel lymph node metastasis in patients with a postoperative diagnosis of ductal carcinoma in situ[J]. Br J Surg, 2014,101(5):488-494.
|
| [28] |
Rodriguez Fernandez J, Martella S, Trifirò G, et al. Sentinel node biopsy in patients with previous breast aesthetic surgery[J]. Ann Surg Oncol,2009,16(4):989-992.
|
| [29] |
Intra M,Viale G,Vila J, et al. Second axillary sentinel lymph node biopsy for breast tumor recurrence:experience of the European Institute of Oncology[J].Ann Surg Oncol,2015,22(7):2372-2377.
|
| [30] |
Boughey JC, Suman VJ, Mittendorf EA, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial[J].JAMA,2013,310(14):1455-1461.
|
| [31] |
Gropper AB, Calvillo KZ, Dominici L, et al. Sentinel lymph node biopsy in pregnant women with breast cancer [J]. Ann Surg Oncol,2014,21(8):2506-2511.
|
| [32] |
叶园园,陈园园,徐枫,等. 乳腺癌前哨淋巴结示踪剂的研究进展[J].上海医药,2015,36(13):21-25.
|
| [33] |
颜宁,刘少杰,彭伟强,等.早期乳腺癌前哨淋巴结活检对预测腋窝淋巴结状态的临床探讨[J]. 当代医学,2013,19(1):107-108.
|
| [34] |
Tummers QR, Verbeek FP, Schaafsma BE, et al. Real-time intraoperative detection of breast cancer using near-infrared fluorescence imaging and methylene blue[J]. Eur J Surg Oncol,2014,40(7):850-858.
|
| [35] |
汪令成,李林均,李雅琼,等.纳米碳在乳腺癌腋窝前哨淋巴结活检中的应用研究[J].湖北中医杂志,2015,37(2):19-20.
|
| [36] |
陈智,覃庆洪,练斌,等.纳米炭混悬液与美蓝在乳腺癌前哨淋巴结活检中的应用研究[J].实用癌症杂志,2015,30(9):1320-1323.
|
| [37] |
张永松, 梁全琨, 钟玲, 等. 纳米炭和亚甲蓝联合核素示踪法在腔镜乳腺癌前哨淋巴结活组织检查中的对照研究[J/CD].中华乳腺病杂志(电子版),2015,9(4):231-235.
|
| [38] |
Wallace AM, Han LK, Povoski SP, et al. Comparative evaluation of[(99m) tc] tilmanocept for sentinel lymph node mapping in breast cancer patients: results of two phase 3 trials [J]. Ann Surg Oncol,2013,20(8):2590-2599.
|
| [39] |
Verbeek FP,Troyan SL,Mieog JS,et al. Near-infrared fluorescence sentinel lymph node mapping in breast cancer:a multicenter experience[J].Breast Cancer Res Treat,2014,143(2):333-342.
|
| [40] |
Sugie T, Sawada T, Tagaya N, et al. Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer[J]. Ann Surg Oncol,2013,20(7):2213-2218.
|
| [41] |
Caruso G, Cipolla C, Costa R, et al. Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients[J]. Acta Radiol,2014,55(1):39-44.
|
| [42] |
陈基施展,吴克瑾. 乳腺癌前哨淋巴结活检假阴性临床研究进展[J].中国实用外科杂志,2015,35(7):787-789.
|
| [43] |
Krishnamurthy S, Meric-Bernstam F, Lucci A, et al. A prospective study comparing touch imprint cytology, frozen section analysis, and rapid cytokeratin immunostain for intraoperative evaluation of axillary sentinel lymph nodes in breast cancer[J]. Cancer,2009,115(7):1555-1562.
|
| [44] |
Xu X, Roberts SA, Pasha TL, et al. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma[J]. Arch Pathol Lab Med,2000,124(9):1310-1313.
|
| [45] |
Diaz NM, Vrcel V, Centeno BA, et al. Modes of benign mechanical transport of breast epithelial cells to axillary lymph nodes[J]. Adv Anat Pathol,2005,12(1):7-9.
|
| [46] |
Caudle AS, Yi M, Hoffman KE, et al. Impact of identification of internal mammary sentinel lymph node metastasis in breast cancer patients[J].Ann Surg Oncol,2014,21(1):60-65.
|
| [47] |
Budach W, Kammers K, Boelke E, et al. Adjuvant radiotherapy of regional lymph nodes in breast cancer-a meta-analysis of randomized trials[J]. Radiat Oncol,2013,8(1):267-273.
|